Matveev V.B., Volkova M.I. ROLE OF DEGARELIX (FIRMAGON) IN THE TREATMENT OF DISSEMINATED PROSTATE CANCER: CAN THE QUALITY OF CASTRATION THERAPY BE IMPROVED? Cancer Urology. 2011;7(1):66-72. (In Russ.) https://doi.org/10.17650/1726-9776-2011-7-1-66-72
Email this article (Login required)
Email the author (Login required) “ABV-press” publishing house
Research Institute of Carcinogenesis
Floor 3, 24 Kashirskoe Shosse, Build. 15,
Moscow 115478, Russian Federation
tel. +7 (499) 929-96-19,
E-mail: abv@abvpress.ru
